Eagle Health Investments LP - Q1 2021 holdings

$255 Million is the total value of Eagle Health Investments LP's 25 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 29.2% .

 Value Shares↓ Weighting
IQV BuyIQVIA HLDGS INC$19,348,000
+49.2%
100,177
+38.4%
7.59%
-8.5%
VRTX BuyVERTEX PHARMACEUTICALS INC$19,006,000
+54.6%
88,444
+70.1%
7.46%
-5.1%
HUM BuyHUMANA INC$18,833,000
+47.3%
44,921
+44.2%
7.39%
-9.6%
AGIO BuyAGIOS PHARMACEUTICALS INC$18,314,000
+506.4%
354,650
+408.8%
7.19%
+272.0%
AZN BuyASTRAZENECA PLCsponsored adr$17,740,000
+54.2%
356,789
+55.1%
6.96%
-5.4%
NTRA BuyNATERA INC$17,099,000
+118.6%
168,394
+114.2%
6.71%
+34.2%
UTHR BuyUNITED THERAPEUTICS CORP DEL$15,573,000
+46.6%
93,100
+33.0%
6.11%
-10.1%
ALNY BuyALNYLAM PHARMACEUTICALS INC$15,274,000
+37.0%
108,179
+26.1%
6.00%
-16.0%
BPMC BuyBLUEPRINT MEDICINES CORP$12,947,000
+86.0%
133,163
+114.6%
5.08%
+14.2%
ARGX BuyARGENX SEsponsored adr$11,740,000
+103.8%
42,632
+117.7%
4.61%
+25.1%
AXNX BuyAXONICS MODULATION TECHNOLOG$11,676,000
+27.9%
194,965
+6.6%
4.58%
-21.5%
TMO SellTHERMO FISHER SCIENTIFIC INC$9,562,000
-17.4%
20,951
-15.7%
3.75%
-49.3%
UTHR NewUNITED THERAPEUTICS CORP DELput$8,364,00050,000
+100.0%
3.28%
ADPT BuyADAPTIVE BIOTECHNOLOGIES COR$8,141,000
+64.8%
202,220
+142.1%
3.20%
+1.1%
INSP NewINSPIRE MED SYS INC$7,752,00037,453
+100.0%
3.04%
JWS BuyJAWS ACQUISITION CORP$6,573,000
+160.3%
496,100
+163.5%
2.58%
+59.8%
MRTX NewMIRATI THERAPEUTICS INC$6,235,00036,400
+100.0%
2.45%
OM BuyOUTSET MED INC$5,292,000
+29.3%
97,300
+35.1%
2.08%
-20.6%
DXCM  DEXCOM INC$4,960,000
-2.8%
13,8000.0%1.95%
-40.3%
GH SellGUARDANT HEALTH INC$4,314,000
+3.1%
28,260
-12.9%
1.69%
-36.7%
SEER BuySEER INC$4,177,000
+272.0%
83,500
+317.5%
1.64%
+128.4%
DFHT BuyDEERFIELD HEALTHCARE TECH AC$4,122,000
+879.1%
340,075
+1159.2%
1.62%
+501.5%
DRNA BuyDICERNA PHARMACEUTICALS INC$4,120,000
+171.1%
161,125
+133.5%
1.62%
+66.4%
FDMT  4D MOLECULAR THERAPEUTICS IN$2,169,000
+4.6%
50,0000.0%0.85%
-35.8%
OLK NewOLINK HLDG ABsponsored ads$1,440,00040,000
+100.0%
0.56%
LGVW ExitLONGVIEW ACQUISITION CORP$0-114,100
-100.0%
-1.44%
ILMN ExitILLUMINA INC$0-15,700
-100.0%
-3.72%
ALXN ExitALEXION PHARMACEUTICALS INC$0-42,929
-100.0%
-4.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-04-23
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-10-20

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings